Canada Markets close in 5 hrs 3 mins

Novartis AG (NVSEF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
77.45-2.90 (-3.61%)
As of 11:59AM EDT. Market open.
Currency in USD

Valuation Measures

Market Cap (intraday) 5177.57B
Enterprise Value 3203.71B
Trailing P/E 25.09
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.58
Price/Book (mrq)3.23
Enterprise Value/Revenue 34.11
Enterprise Value/EBITDA 611.33

Trading Information

Stock Price History

Beta (5Y Monthly) 0.37
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 398.00
52 Week Low 368.65
50-Day Moving Average 387.12
200-Day Moving Average 386.51

Share Statistics

Avg Vol (3 month) 37.21k
Avg Vol (10 day) 38.1k
Shares Outstanding 52.27B
Float 2.13B
% Held by Insiders 15.77%
% Held by Institutions 132.74%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 43.08
Forward Annual Dividend Yield 43.98%
Trailing Annual Dividend Rate 33.04
Trailing Annual Dividend Yield 33.78%
5 Year Average Dividend Yield 4N/A
Payout Ratio 498.53%
Dividend Date 3Mar. 07, 2018
Ex-Dividend Date 4Mar. 02, 2020
Last Split Factor 240:1
Last Split Date 3May 06, 2001

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin 14.33%
Operating Margin (ttm)26.75%

Management Effectiveness

Return on Assets (ttm)6.75%
Return on Equity (ttm)13.25%

Income Statement

Revenue (ttm)49.58B
Revenue Per Share (ttm)21.76
Quarterly Revenue Growth (yoy)0.40%
Gross Profit (ttm)34.68B
EBITDA 17.97B
Net Income Avi to Common (ttm)7.1B
Diluted EPS (ttm)3.09
Quarterly Earnings Growth (yoy)-5.20%

Balance Sheet

Total Cash (mrq)10.69B
Total Cash Per Share (mrq)4.7
Total Debt (mrq)38.17B
Total Debt/Equity (mrq)69.98
Current Ratio (mrq)0.91
Book Value Per Share (mrq)23.95

Cash Flow Statement

Operating Cash Flow (ttm)13.19B
Levered Free Cash Flow (ttm)14.06B